Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer-Reference-Cited by-同舟云学术

Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer

Published:2021-10 Issue: Volume:Volume 14 Page:7025-7042
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Sial Nuzhat,Saeed Saba^ORCID,Ahmad Mukhtiar,Hameed Yasir^ORCID,Rehman Abdul,Abbas Mustansar,Asif Rizwan,Ahmed Hamad,Hussain Muhammad Safdar,Rehman Jalil Ur,Atif Muhammad,Khan Muhammad Rashid

Publisher

Informa UK Limited

Subject

General Medicine

Reference40 articles.

1. Cancer prevention from the perspective of global cancer burden patterns

2. Mechanisms of metastasis

3. Transmembrane emp24 domain proteins in development and disease.

Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and characterization of the receptors of a microneme adhesive repeat domain of Eimeria maxima microneme protein 3 in chicken intestine epithelial cells;Poultry Science;2024-04

2. Comprehensive pan-cancer analysis reveals VSIR as a candidate immunologic, diagnostic, and prognostic biomarker;American Journal of Translational Research;2024

3. Unlocking the diagnostic, prognostic roles, and immune implications of BAX gene expression in pan-cancer analysis;American Journal of Translational Research;2024

4. Bone morphogenetic protein 1: a prognostic indicator and potential biomarker in three cancer types;American Journal of Translational Research;2024

5. TMED2 Induces Cisplatin Resistance in Breast Cancer via Targeting the KEAP1-Nrf2 Pathway;Current Medical Science;2023-08-24